Cargando…
Cardiac Injury and Outcomes of Patients With COVID-19 in New York City
BACKGROUND: Prior studies demonstrated that elevated troponin in patients with COVID-19 was associated with increased in-hospital mortality. However, the association of cardiac injury and electrocardiogram (ECG) changes remains unclear. The aim of this study was to investigate the association of car...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682483/ https://www.ncbi.nlm.nih.gov/pubmed/33279410 http://dx.doi.org/10.1016/j.hlc.2020.10.025 |
_version_ | 1783612696255528960 |
---|---|
author | Maeda, Tetsuro Obata, Reiichiro Rizk, Dahlia Kuno, Toshiki |
author_facet | Maeda, Tetsuro Obata, Reiichiro Rizk, Dahlia Kuno, Toshiki |
author_sort | Maeda, Tetsuro |
collection | PubMed |
description | BACKGROUND: Prior studies demonstrated that elevated troponin in patients with COVID-19 was associated with increased in-hospital mortality. However, the association of cardiac injury and electrocardiogram (ECG) changes remains unclear. The aim of this study was to investigate the association of cardiac injury with ECG abnormality and with in-hospital mortality. METHODS: We conducted a retrospective cohort study of patients who were hospitalised with COVID-19 between 13 March and 31 March 2020. Those patients with troponin I measurement were included in the study and divided into those who had elevated troponin I (cardiac injury group) and those who did not (no cardiac injury group). Statistical analyses were performed to compare differences between the groups, and a multivariate logistic regression model was constructed to assess the effect of cardiac injury on in-hospital mortality. RESULTS: One hundred and eight-one (181) patients were included, 54 of whom were in the cardiac injury group and 127 in the no cardiac injury group. The mean age was 64.0±16.6 years and 55.8% were male. The cardiac injury group was more likely to be older, have a history of coronary artery disease, atrial fibrillation and congestive heart failure compared to the no cardiac injury group (all p<0.05); there was no difference in presence of chest pain (cardiac injury group versus no cardiac injury group: 17.0% versus 22.5%, p=0.92); the cardiac injury group had a significantly higher value of brain natriuretic peptide, procalcitonin, interleukin-6 and D-dimer (all p<0.05); they had numerically more frequent ECG abnormalities such as T wave inversion (13.2% versus 7.5%, p=0.23) and ST depression (1.9% versus 0.0%, p=0.13) although statistically not significant; they had significantly higher in-hospital mortality (42.3% versus 12.6%, p<0.001). With a multivariate logistic regression model, age (odds ratio [95% confidence interval]: 1.033 [1.002–1.065], p=0.034) and cardiac injury (3.25 [1.40–7.54], p=0.006) were independent predictors of in-hospital mortality. CONCLUSIONS: Patients with COVID-19 with elevated troponin I had a relatively low proportion of chest pain and ECG abnormality. Cardiac injury was independently associated with in-hospital mortality. |
format | Online Article Text |
id | pubmed-7682483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76824832020-11-24 Cardiac Injury and Outcomes of Patients With COVID-19 in New York City Maeda, Tetsuro Obata, Reiichiro Rizk, Dahlia Kuno, Toshiki Heart Lung Circ Original Article BACKGROUND: Prior studies demonstrated that elevated troponin in patients with COVID-19 was associated with increased in-hospital mortality. However, the association of cardiac injury and electrocardiogram (ECG) changes remains unclear. The aim of this study was to investigate the association of cardiac injury with ECG abnormality and with in-hospital mortality. METHODS: We conducted a retrospective cohort study of patients who were hospitalised with COVID-19 between 13 March and 31 March 2020. Those patients with troponin I measurement were included in the study and divided into those who had elevated troponin I (cardiac injury group) and those who did not (no cardiac injury group). Statistical analyses were performed to compare differences between the groups, and a multivariate logistic regression model was constructed to assess the effect of cardiac injury on in-hospital mortality. RESULTS: One hundred and eight-one (181) patients were included, 54 of whom were in the cardiac injury group and 127 in the no cardiac injury group. The mean age was 64.0±16.6 years and 55.8% were male. The cardiac injury group was more likely to be older, have a history of coronary artery disease, atrial fibrillation and congestive heart failure compared to the no cardiac injury group (all p<0.05); there was no difference in presence of chest pain (cardiac injury group versus no cardiac injury group: 17.0% versus 22.5%, p=0.92); the cardiac injury group had a significantly higher value of brain natriuretic peptide, procalcitonin, interleukin-6 and D-dimer (all p<0.05); they had numerically more frequent ECG abnormalities such as T wave inversion (13.2% versus 7.5%, p=0.23) and ST depression (1.9% versus 0.0%, p=0.13) although statistically not significant; they had significantly higher in-hospital mortality (42.3% versus 12.6%, p<0.001). With a multivariate logistic regression model, age (odds ratio [95% confidence interval]: 1.033 [1.002–1.065], p=0.034) and cardiac injury (3.25 [1.40–7.54], p=0.006) were independent predictors of in-hospital mortality. CONCLUSIONS: Patients with COVID-19 with elevated troponin I had a relatively low proportion of chest pain and ECG abnormality. Cardiac injury was independently associated with in-hospital mortality. Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. 2021-06 2020-11-23 /pmc/articles/PMC7682483/ /pubmed/33279410 http://dx.doi.org/10.1016/j.hlc.2020.10.025 Text en © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Maeda, Tetsuro Obata, Reiichiro Rizk, Dahlia Kuno, Toshiki Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title | Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title_full | Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title_fullStr | Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title_full_unstemmed | Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title_short | Cardiac Injury and Outcomes of Patients With COVID-19 in New York City |
title_sort | cardiac injury and outcomes of patients with covid-19 in new york city |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682483/ https://www.ncbi.nlm.nih.gov/pubmed/33279410 http://dx.doi.org/10.1016/j.hlc.2020.10.025 |
work_keys_str_mv | AT maedatetsuro cardiacinjuryandoutcomesofpatientswithcovid19innewyorkcity AT obatareiichiro cardiacinjuryandoutcomesofpatientswithcovid19innewyorkcity AT rizkdahlia cardiacinjuryandoutcomesofpatientswithcovid19innewyorkcity AT kunotoshiki cardiacinjuryandoutcomesofpatientswithcovid19innewyorkcity |